AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2010

Oct 29, 2010

30718_dirs_2010-10-29_1350824d-918a-4b92-9165-b5c40fb0a875.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2010-10-28

Reporting Person: OCONNELL HOWARD V (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-28	Stock Option	$61.46	A	5000	Acquired	2020-10-27	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	127629	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$63.03	2019-10-28	Common Stock (5000)	5000	Indirect
Stock Option	$65.47	2018-10-22	Common Stock (5000)	5000	Indirect
Stock Option	$66.59	2017-10-24	Common Stock (5000)	5000	Indirect
Stock Option	$56.17	2016-10-25	Common Stock (5000)	5000	Indirect
Stock Option	$54.68	2015-10-26	Common Stock (5000)	5000	Indirect
Stock Option	$37.1	2014-10-21	Common Stock (5000)	5000	Indirect
Stock Option	$32.9	2013-10-23	Common Stock (5000)	5000	Indirect
Stock Option	$30.65	2012-10-24	Common Stock (5000)	5000	Indirect
Stock Option	$29.1	2011-10-18	Common Stock (3000)	3000	Indirect
Stock Option	$52.6565	2010-11-09	Common Stock (10000)	10000	Indirect

Footnotes

F1: Transferred to Howard V. O'Connell, Jr. Grantor Retained Annuity Trust on Nov. 27, 2009.